Mostrar el registro sencillo del ítem

dc.contributor.author
Fleurence, Rachael L.  
dc.contributor.author
Kent, Seamus  
dc.contributor.author
Adamson, Blythe  
dc.contributor.author
Tcheng, James  
dc.contributor.author
Balicer, Ran  
dc.contributor.author
Ross, Joseph S.  
dc.contributor.author
Haynes, Kevin  
dc.contributor.author
Muller, Patrick  
dc.contributor.author
Campbell, Jon  
dc.contributor.author
Bouée-Benhamiche, Elsa  
dc.contributor.author
García Martí, Sebastián  
dc.contributor.author
Ramsey, Scott  
dc.date.available
2025-07-15T12:27:40Z  
dc.date.issued
2024-06  
dc.identifier.citation
Fleurence, Rachael L.; Kent, Seamus; Adamson, Blythe; Tcheng, James; Balicer, Ran; et al.; Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force; Elsevier; Value In Health; 27; 6; 6-2024; 692-701  
dc.identifier.issn
1098-3015  
dc.identifier.uri
http://hdl.handle.net/11336/266081  
dc.description.abstract
This ISPOR Good Practices report provides a framework for assessing the suitability of electronic health records data for use in health technology assessments (HTAs). Although electronic health record (EHR) data can fill evidence gaps and improve decisions, several important limitations can affect its validity and relevance. The ISPOR framework includes 2 components: data delineation and data fitness for purpose. Data delineation provides a complete understanding of the data and an assessment of its trustworthiness by describing (1) data characteristics; (2) data provenance; and (3) data governance. Fitness for purpose comprises (1) data reliability items, ie, how accurate and complete the estimates are for answering the question at hand and (2) data relevance items, which assess how well the data are suited to answer the particular question from a decision-making perspective. The report includes a checklist specific to EHR data reporting: the ISPOR SUITABILITY Checklist. It also provides recommendations for HTA agencies and policy makers to improve the use of EHR-derived data over time. The report concludes with a discussion of limitations and future directions in the field, including the potential impact from the substantial and rapid advances in the diffusion and capabilities of large language models and generative artificial intelligence. The report's immediate audiences are HTA evidence developers and users. We anticipate that it will also be useful to other stakeholders, particularly regulators and manufacturers, in the future.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
REAL-WORLD EVIDENCE  
dc.subject
HEALTH TECHNOLOGY ASSESSMENT  
dc.subject
ISPORT GOOD PRACTICES REPORT  
dc.subject.classification
Políticas y Servicios de Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2025-07-14T10:47:38Z  
dc.journal.volume
27  
dc.journal.number
6  
dc.journal.pagination
692-701  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Fleurence, Rachael L.. National Institutes of Health; Estados Unidos  
dc.description.fil
Fil: Kent, Seamus. Erasmus University;  
dc.description.fil
Fil: Adamson, Blythe. Flatiron Health; Estados Unidos  
dc.description.fil
Fil: Tcheng, James. University of Duke; Estados Unidos  
dc.description.fil
Fil: Balicer, Ran. Clalit Health Services; Israel  
dc.description.fil
Fil: Ross, Joseph S.. University of Yale; Estados Unidos  
dc.description.fil
Fil: Haynes, Kevin. Janssen Research And Development; Estados Unidos  
dc.description.fil
Fil: Muller, Patrick. National Institute For Health And Care Excellence; Reino Unido  
dc.description.fil
Fil: Campbell, Jon. National Pharmaceutical Council; Estados Unidos  
dc.description.fil
Fil: Bouée-Benhamiche, Elsa. Institut National Du Cancer; Francia  
dc.description.fil
Fil: García Martí, Sebastián. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina  
dc.description.fil
Fil: Ramsey, Scott. Fred Hutchinson Cancer Center; Estados Unidos  
dc.journal.title
Value In Health  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S109830152400069X  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.jval.2024.01.019